We report the successful outcome of a patient with anti-M antibodies with a previous history of severe hemolysis of erythrocytes. Serial plasma exchange from the first trimester combined with ultrasound monitoring of the fetal middle cerebral artery blood velocity was implemented. This management allowed a favorable pregnancy outcome of an infant born by an elective caesarean section at 32 weeks 6/7 with a normal Apgar score at 8/9/10. The other therapeutic alternatives such as intravenous immunoglobulin and in utero fetal blood transfusions are discussed
Alloimmunisation against paternal human platelet antigen (HPA) can result in fetomaternal alloimmune...
Objective. Diagnosis and treatment of haemolytic disease of the fetus has considerably progressed si...
We report herein three cases of severe fetal thrombocytopenia due to anti-human platelet antigen (HP...
Intrauterine transfusion is the standard antenatal treatment for a fetus with severe anemia. Plasmap...
OBJECTIVE: The objective of the study was to report the maternal and perinatal outcome in patients w...
AbstractObjectiveTo present intensive intrauterine treatment of recurrent early onset fetal erythrob...
Haemolytic disease of the foetus and newborn (HDFN) is caused by maternal red blood cells (RBC) allo...
Transfusion only occasionally gives rise to antibody production, because blood cells per se are not ...
Twenty one pregnancies complicated by alloimmunization were managed by the use of intravascular meth...
Rhesus D alloimmunisation remains a major problem despite the use of anti-D prophylaxis. Immunisatio...
Before the introduction of anti-D immune globulin, hemolytic disease of the fetus and newborn affect...
There are few case reports of hemolytic disease in fetuses and newborns (HDFN) caused by alloantibod...
There has been a dramatic reduction in the incidence of neonatal mortality due to fetal hemolytic di...
Neonatal alloimmune thrombocytopenia (NAIT) can cause severe bleeding in the central nervous system ...
AIM: Invasive techniques such as amniocentesis and cordocentesis are used for the diagnosis and tre...
Alloimmunisation against paternal human platelet antigen (HPA) can result in fetomaternal alloimmune...
Objective. Diagnosis and treatment of haemolytic disease of the fetus has considerably progressed si...
We report herein three cases of severe fetal thrombocytopenia due to anti-human platelet antigen (HP...
Intrauterine transfusion is the standard antenatal treatment for a fetus with severe anemia. Plasmap...
OBJECTIVE: The objective of the study was to report the maternal and perinatal outcome in patients w...
AbstractObjectiveTo present intensive intrauterine treatment of recurrent early onset fetal erythrob...
Haemolytic disease of the foetus and newborn (HDFN) is caused by maternal red blood cells (RBC) allo...
Transfusion only occasionally gives rise to antibody production, because blood cells per se are not ...
Twenty one pregnancies complicated by alloimmunization were managed by the use of intravascular meth...
Rhesus D alloimmunisation remains a major problem despite the use of anti-D prophylaxis. Immunisatio...
Before the introduction of anti-D immune globulin, hemolytic disease of the fetus and newborn affect...
There are few case reports of hemolytic disease in fetuses and newborns (HDFN) caused by alloantibod...
There has been a dramatic reduction in the incidence of neonatal mortality due to fetal hemolytic di...
Neonatal alloimmune thrombocytopenia (NAIT) can cause severe bleeding in the central nervous system ...
AIM: Invasive techniques such as amniocentesis and cordocentesis are used for the diagnosis and tre...
Alloimmunisation against paternal human platelet antigen (HPA) can result in fetomaternal alloimmune...
Objective. Diagnosis and treatment of haemolytic disease of the fetus has considerably progressed si...
We report herein three cases of severe fetal thrombocytopenia due to anti-human platelet antigen (HP...